National Institute For Medical Research

National Institute For Medical Research The National Institute for Medical Research (NIMR) is a government research institution under the Ministry for Health established in 1979.

NIMR has the dual mandate to conduct and regulate health research on Tanzania Mainland. The National Institute for Medical Research (NIMR) is the largest public health research institution in Tanzania. It was established by the Parliament Act No. 23 of 1979 as a parastatal organization under the Ministry of Health. The establishment of NIMR was in recognition by the government of the need to generate scientific information required in the development of better methods and techniques of enhancing disease management, prevention and control in the country.

14/01/2026

๐Ÿ“ข ๐„๐ฑ๐œ๐ข๐ญ๐ข๐ง๐  ๐ฎ๐ฉ๐๐š๐ญ๐ž๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐๐ˆ๐Œ๐‘!

Our Q2 2025/26 Newsletter is out โ€“ packed with research highlights, success stories, and key developments shaping the future of health.
๐Ÿ‘‰ Check it out: https://drive.google.com/file/d/15UpWADAUl_gjIWGehTMQZpFFkFlkNbR9/view?usp=sharing

12/01/2026
๐๐ˆ๐Œ๐‘ ๐„๐ฆ๐ž๐ซ๐ ๐ž๐ฌ ๐š๐ฌ ๐š ๐†๐ฅ๐จ๐›๐š๐ฅ ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐‹๐ž๐š๐๐ž๐ซ ๐ข๐ง ๐„๐ƒ๐‚๐“๐-๐’๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ž๐ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐กThe National Institute for Medical Resear...
11/01/2026

๐๐ˆ๐Œ๐‘ ๐„๐ฆ๐ž๐ซ๐ ๐ž๐ฌ ๐š๐ฌ ๐š ๐†๐ฅ๐จ๐›๐š๐ฅ ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐‹๐ž๐š๐๐ž๐ซ ๐ข๐ง ๐„๐ƒ๐‚๐“๐-๐’๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ž๐ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

The National Institute for Medical Research (NIMR) in Tanzania, has been recognized as a leading contributor to internationally competitive health research following its strong performance in EDCTP2-supported scientific publications.
Recent analyses place NIMR at 23rd position globally among all institutions contributing to EDCTP2 publications, positioning the Institute within the top 25 worldwide. Within sub-Saharan Africa, NIMR ranks among the top 10 research institutions and in East Africa, it stands as the second-leading institution, surpassed only by Makerere University and ranking ahead of several long-established regional research centres.
This achievement reflects sustained scientific productivity, high-quality research output, and impactful contributions across EDCTP priority research areas including HIV, tuberculosis, malaria, lower respiratory infections and emerging infectious diseases. The Institute work continues to generate evidence that informs policy, strengthens health systems and advances global and continental health agendas.
NIMRโ€™s standing not only affirms its role as Tanzaniaโ€™s premier medical research institution but also highlights the countryโ€™s growing visibility and leadership in global health research. The Institute performance provides a strong empirical foundation for its active engagement and leadership in EDCTP3, large multi-country research consortia, and regional capacity-strengthening initiatives.
As NIMR continues to expand its research partnerships and scientific reach, this recognition reinforces its commitment to excellence, collaboration, and the generation of evidence that addresses pressing health challenges in Africa and beyond.
Health

10/01/2026

POLICY DIALOGUE MEETING JANUARY 2026
Mkutano wa Majadiliano ya Sera uliofanyika tarehe 8 Januari 2026 katika Ukumbi wa CEEMI, Ofisi Ndogo ya NIMR, Jijini Dar es Salaam, uliwahusisha Watafiti, Watunga Sera, Watoa Maamuzi wa Sekta ya Afya, na wadau mbalimbali. Mkutano huu ulilenga kuimarisha matumizi ya ushahidi wa kisayansi katika kuandaa na kutekeleza Sera za Taifa kuhusu maandalizi, kinga, na mwitikio dhidi ya milipuko ya magonjwa

๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐—ฝ๐—ฎ๐˜๐—ฎ ๐—ง๐˜‚๐˜‡๐—ผ ๐—ž๐˜‚๐˜๐—ผ๐—ธ๐—ฎ ๐—ข๐—ณ๐—ถ๐˜€๐—ถ ๐˜†๐—ฎ ๐—ช๐—ฎ๐˜‡๐—ถ๐—ฟ๐—ถ ๐— ๐—ธ๐˜‚๐˜‚ โ€“ ๐—ž๐—ฎ๐˜‡๐—ถ, ๐—”๐—ท๐—ถ๐—ฟ๐—ฎ ๐—ป๐—ฎ ๐— ๐—ฎ๐—ต๐˜‚๐˜€๐—ถ๐—ฎ๐—ป๐—ผ ๐˜†๐—ฎ ๐—ž๐—ฎ๐˜‡๐—ถTaasisi ya Taifa ya Utafiti wa Magonjwa y...
09/01/2026

๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐—ฝ๐—ฎ๐˜๐—ฎ ๐—ง๐˜‚๐˜‡๐—ผ ๐—ž๐˜‚๐˜๐—ผ๐—ธ๐—ฎ ๐—ข๐—ณ๐—ถ๐˜€๐—ถ ๐˜†๐—ฎ ๐—ช๐—ฎ๐˜‡๐—ถ๐—ฟ๐—ถ ๐— ๐—ธ๐˜‚๐˜‚ โ€“ ๐—ž๐—ฎ๐˜‡๐—ถ, ๐—”๐—ท๐—ถ๐—ฟ๐—ฎ ๐—ป๐—ฎ ๐— ๐—ฎ๐—ต๐˜‚๐˜€๐—ถ๐—ฎ๐—ป๐—ผ ๐˜†๐—ฎ ๐—ž๐—ฎ๐˜‡๐—ถ

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) imepokea tuzo maalum kutoka Ofisi ya Waziri Mkuu โ€“ Kazi, Ajira na Mahusiano ya Kazi ikiwa ni kutambua mchango wake mkubwa katika kutoa nafasi nyingi za mafunzo kwa vitendo (internship) kwa vijana.
Tuzo hiyo ni uthibitisho wa dhamira ya NIMR katika kuendeleza ujuzi kwa vitendo, kukuza uwezo wa kitaalamu, na kuwawezesha vijana, sambamba na mchango wake katika maendeleo ya rasilimali watu katika sekta ya utafiti wa afya nchini.
NIMR itaendelea kushirikiana na Serikali ya Awamu ya Sita inayoongozwa na Mheshimiwa Dkt Samia Suluhu Hassan, Rais wa Jamhuri ya Muungano wa Tanzania na wadau mbalimbali katika kuandaa kizazi chenye maarifa, ujuzi na mchango chanya kwa maendeleo ya Taifa.
.

๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐—ผ๐—ป๐—ด๐—ผ๐˜‡๐—ฎ ๐— ๐—ฑ๐—ฎ๐—ต๐—ฎ๐—น๐—ผ ๐˜„๐—ฎ ๐—ฆ๐—ฒ๐—ฟ๐—ฎ ๐—ž๐˜‚๐—ต๐—ฎ๐—ธ๐—ถ๐—ธ๐—ถ๐˜€๐—ต๐—ฎ ๐—จ๐˜€๐—ต๐—ฎ๐—ต๐—ถ๐—ฑ๐—ถ ๐˜„๐—ฎ ๐—ž๐—ถ๐˜€๐—ฎ๐˜†๐—ฎ๐—ป๐˜€๐—ถ ๐—จ๐—ป๐—ฎ๐˜๐˜‚๐—บ๐—ถ๐—ธ๐—ฎ ๐—ž๐˜‚๐—ธ๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ ๐— ๐—ถ๐—น๐—ถ๐—ฝ๐˜‚๐—ธ๐—ผ ๐˜†๐—ฎ ๐— ๐—ฎ๐—ด๐—ผ๐—ป๐—ท๐˜„๐—ฎTaasisi ya Taifa ...
09/01/2026

๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐—ผ๐—ป๐—ด๐—ผ๐˜‡๐—ฎ ๐— ๐—ฑ๐—ฎ๐—ต๐—ฎ๐—น๐—ผ ๐˜„๐—ฎ ๐—ฆ๐—ฒ๐—ฟ๐—ฎ ๐—ž๐˜‚๐—ต๐—ฎ๐—ธ๐—ถ๐—ธ๐—ถ๐˜€๐—ต๐—ฎ ๐—จ๐˜€๐—ต๐—ฎ๐—ต๐—ถ๐—ฑ๐—ถ ๐˜„๐—ฎ ๐—ž๐—ถ๐˜€๐—ฎ๐˜†๐—ฎ๐—ป๐˜€๐—ถ ๐—จ๐—ป๐—ฎ๐˜๐˜‚๐—บ๐—ถ๐—ธ๐—ฎ ๐—ž๐˜‚๐—ธ๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ ๐— ๐—ถ๐—น๐—ถ๐—ฝ๐˜‚๐—ธ๐—ผ ๐˜†๐—ฎ ๐— ๐—ฎ๐—ด๐—ผ๐—ป๐—ท๐˜„๐—ฎ

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) leo, tarehe 8 Januari 2026, imeendesha mkutano wa majadiliano ya sera uliowakutanisha watafiti, watunga sera, watoa maamuzi wa sekta ya afya na wadau mbalimbali, kwa lengo la kuimarisha matumizi ya ushahidi wa kisayansi katika kuandaa na kutekeleza sera zinazohusu maandalizi, kinga na mwitikio wa taifa dhidi ya magonjwa yanayolipuka na kurejea mara kwa mara.
Akifungua mkutano huo, Mgeni Rasmi Dkt. Ahmad Mohamed Makuwani, Mkurugenzi wa Huduma ya Afya ya Uzazi, Magonjwa ya Wanawake na Watoto kutoka Wizara ya Afya, akimwakilisha Mganga Mkuu wa Serikali, amesema kuwa majadiliano hayo yanakuja katika kipindi muhimu kwa taifa, ambapo kumekuwa na kuendelea kushuhudiwa kwa milipuko ya magonjwa k**a kipindupindu, dengue, COVID-19 na Marburg. Amesema hali hiyo inaweka shinikizo kubwa kwa mifumo ya afya na hivyo kuhitaji sera zinazojengwa juu ya ushahidi madhubuti wa kisayansi.
โ€œMkutano huu ni jukwaa muhimu la kutafakari mazingira ya milipuko ya magonjwa nchini na kuimarisha uwezo wa pamoja wa taifa katika kuzuia, kugundua mapema na kukabiliana na vitisho vya afya ya jamii vya sasa na vya baadaye,โ€ amebainisha Dkt. Makuwani. Ameongeza kuwa majadiliano ya sera ni nyenzo muhimu ya kuunganisha tafiti na maamuzi ya kisera ili kufanikisha uamuzi unaozingatia ushahidi.
Aidha, Dkt. Makuwani amesisitiza umuhimu wa kuimarisha tafiti za ndani, ikiwemo utafiti wa tiba asili, akibainisha kuwa uzoefu wa mlipuko wa UVIKO-19 umeonesha mchango wa tiba asili katika kupunguza madhara kwa jamii. Akitoa wito, ameahidi kuwa Serikali itaendelea kuwekeza katika tafiti za tiba asili na mifumo ya kitaifa ya utafiti.
Kwa upande wake, Mkurugenzi Mkuu wa NIMR, Profesa Said Aboud, amesema kuwa mkutano huo umeandaliwa mahsusi kushughulikia masuala nyeti yanayohusiana na magonjwa yenye uwezekano wa kusababisha milipuko, huku ukilenga kuhakikisha matokeo ya tafiti yanatafsiriwa na kutumika moja kwa moja katika sera na mipango ya kitaifa.
Prof. Aboud ameeleza kuwa mkutano huo ni jukwaa la tafsiri ya maarifa, linalowaunganisha watafiti, watunga sera na watekelezaji ili kujadili ushahidi uliopo, kubadilishana uzoefu na kuandaa mapendekezo yatakayosaidia kuimarisha maandalizi, kinga na mwitikio wa taifa dhidi ya milipuko ya magonjwa.
โ€œTafiti zinaonesha kuwa maandalizi madhubuti dhidi ya milipuko yanategemea mifumo imara ya ufuatiliaji wa magonjwa, nguvu kazi ya afya iliyo imara na minyororo thabiti ya upatikanaji wa vifaa tiba,โ€ ameongeza Prof. Aboud.
James Tumain Tengia, mwakilishi kutoka Wizara ya TAMISEMI, ameipongeza NIMR kwa kuandaa mkutano huo, akisema kuwa umefanikiwa kuwakutanisha watafiti, watunga sera na watoa maamuzi ili kuchakata matokeo ya tafiti mbalimbali na kuja na maoni yatakayosaidia kuboresha sera na miongozo ya utoaji wa huduma za afya.
Elizabeth Shayo, Mtafiti Mkuu kutoka NIMR, amesema kuwa mkutano huo umekuwa na manufaa makubwa kwa kuwa umetoa fursa ya kujadili namna bora ya kupambana na magonjwa ya mlipuko yanayoweza kutokea nchini.
Akitoa majumuisho ya mkutano huo, Dkt. Ernest Mazigo, mtafiti kutoka NIMR na mratibu wa mdahalo huo amesema kuwa wadau ambao ni watunga sera na watoa maamuzi wamepokea mapendekezo mbalimbali yaliyotolewa na wameanza kuangalia namna ya kuyaingiza katika mifumo na utekelezaji wa sera za afya.
Mdahalo huo wa siku moja uliofanyika katika Ukumbi wa CEEMI, ofisi ndogo za NIMR jijini Dar es Salaam, ulijikita katika kuangalia namna ushahidi wa kisayansi unavyoweza kuboresha sera na miongozo ya utoaji wa huduma za afya nchini, pamoja na kubaini vipaumbele vya tafiti na mapungufu ya utekelezaji. Mdahalo huo uliandaliwa kwa ushirikiano wa wataalamu kutoka Kurugenzi ya Kuratibu na Kukuza Utafiti ya NIMR akiwemo Mr. Emmanuel Makundi, Dkt. Stellah Kilima na Dkt. Elizabeth Shayo, huku Profesa Moshi Ntabaye aliyeendesha mjadala huo akishiriki kikamilifu katika kufanikisha mdahalo huo wa sera.

๐—ก๐—œ๐— ๐—ฅ ๐—จ๐—ป๐˜ƒ๐—ฒ๐—ถ๐—น๐˜€ ๐—š๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ ๐—˜๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ต๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ฒ๐—ฑ๐—ผ๐—บ๐—ถ๐—ป๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—•๐—ฎ๐—ฐ๐˜๐—ฒ๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฃ๐—ฎ๐˜๐—ต๐—ผ๐—ด๐—ฒ๐—ป๐˜€ ๐—ถ๐—ป ๐—”๐—ฐ๐˜‚๐˜๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ถ๐—ป ๐—ง๐—ฎ๐—ป๐˜‡๐—ฎ๐—ป๐—ถ๐—ฎThe...
24/12/2025

๐—ก๐—œ๐— ๐—ฅ ๐—จ๐—ป๐˜ƒ๐—ฒ๐—ถ๐—น๐˜€ ๐—š๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ ๐—˜๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ต๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ฒ๐—ฑ๐—ผ๐—บ๐—ถ๐—ป๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—•๐—ฎ๐—ฐ๐˜๐—ฒ๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฃ๐—ฎ๐˜๐—ต๐—ผ๐—ด๐—ฒ๐—ป๐˜€ ๐—ถ๐—ป ๐—”๐—ฐ๐˜‚๐˜๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ถ๐—ป ๐—ง๐—ฎ๐—ป๐˜‡๐—ฎ๐—ป๐—ถ๐—ฎ

The National Institute for Medical Research (NIMR) disseminated on 22nd December 2025 research findings from the project titled Genomic characterization of Acute Respiratory Infections (ARI) Pathogens in Tanzania at the Ministry of Health (MOH) in Mtumba, Dodoma. The event was graced by the Acting DPS Dr Vida Mbaga together with heads of sections in surveillance from the MoH, representatives from ILI/SARI sentinel sites, National Public Health Laboratory (NPHL) and the US Centres for Disease Control and Prevention (CDC) Tanzania underscoring the importance of multisectoral collaboration in addressing public health priorities.
Presenting the most salient findings, Dr Juma Kisuse, representing NIMR, presented that the study applied targeted Next-Generation Sequencing (tNGS) technology to comprehensively profile circulating respiratory pathogens and their associated antimicrobial resistance (AMR) genes. A total of 484 samples were randomly selected from the national ILI/SARI surveillance system and analyzed, covering the period from October 2023 to September 2024 across five geographical zones: Northern, Lake, Central, Coastal, and Southern Highlands. The study revealed a predominance of bacterial pathogens, dominated by Streptococcus mitis, Streptococcus pneumoniae, and Haemophilus influenzae, compared to the most commonly viruses reported.
The findings further revealed a high burden of bacterial and viral co-infections, with 89.5% of patients harbouring 2-14 pathogens. Thirty percent of patients exhibited mixed bacterial and viral co-infections, underscoring the complexity of diagnosis and management of ARI. Moreover, bacterial pathogens circulated year-round with clear peaks in June to December while viral pathogens showed sharper pathogen-specific peaks - CMV in March, Adenovirus in May, and SARS-CoV-2 in January/September. The study findings further indicated a high prevalence of Antimicrobial Resistance (AMR) Genes associated with Doxycycline, Beta-lactamases and Sulphonamides.
In concuding remarks, NIMR DG, Prof Said Aboud commented that Streptococcus mitis, S pneumoniae and H influenzae infections were more frequent than viruses demonstrating a shift in trend from viruses to bacteria. He commented on the importance to strengthen immunization against Haemophilus influenza type b which is part of penta 5. He remarked to broaden the scope of ARI surveillance from current SARS Cov-2 and influenza virus to detect more pathogens with more possible use of tNGS in order to guide the interventions on ARI. Furthermore, he thanked the entire study team - Dr Mary Mayige, Dr Clara Lubinza, Dr Gibson Kagaruki, Sudi Lwitiho and Dr Seth Misago. of Health -NextGenerationSequencing #

๐—•๐—ฒ๐˜†๐—ผ๐—ป๐—ฑ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐—ถ๐—น๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ: ๐—ช๐—ฎ๐˜€๐˜๐—ฒ๐˜„๐—ฎ๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—ป๐˜ƒ๐—ถ๐—ฟ๐—ผ๐—ป๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐— ๐—ผ๐—ป๐—ถ๐˜๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฅ๐—ฒ๐˜ƒ๐—ฒ๐—ฎ๐—น ๐—›๐—ผ๐˜๐˜€๐—ฝ๐—ผ๐˜๐˜€ ๐—ผ๐—ณ ๐—”๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น-๐—ฅ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐˜ โ€œ๐—ฆ๐˜‚๐—ฝ๐—ฒ๐—ฟ๐—ฏ...
12/12/2025

๐—•๐—ฒ๐˜†๐—ผ๐—ป๐—ฑ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐—ถ๐—น๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ: ๐—ช๐—ฎ๐˜€๐˜๐—ฒ๐˜„๐—ฎ๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—ป๐˜ƒ๐—ถ๐—ฟ๐—ผ๐—ป๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐— ๐—ผ๐—ป๐—ถ๐˜๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฅ๐—ฒ๐˜ƒ๐—ฒ๐—ฎ๐—น ๐—›๐—ผ๐˜๐˜€๐—ฝ๐—ผ๐˜๐˜€ ๐—ผ๐—ณ ๐—”๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น-๐—ฅ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐˜ โ€œ๐—ฆ๐˜‚๐—ฝ๐—ฒ๐—ฟ๐—ฏ๐˜‚๐—ด๐˜€โ€

A recent study presented at the 7th Africa Continental World Antimicrobial Awareness Week (WAAW) event has unveiled the โ€œenvironmental resistomeโ€ in Tanzania. Using advanced genomic tools to analyse wastewater and environmental surveillance (WES) from Dar es Salaam and Tanga, pilot sites where the project is being implemented, the study's preliminary results provide a population-level snapshot of circulating antimicrobial resistance (AMR) genes in environmental ecosystems. The researchers detected signals of resistance to common antimicrobial drugs and pinpointed hotspots of antimicrobial resistance โ€œsuperbugโ€. These results offer a complementary tool for surveillance to inform targeted interventions, bridging the One Health gap created by the traditional focus on clinical surveillance, often overlooking the environmental reservoirs of AMR. "Using advanced genomic tools, we tested local wastewater and uncovered a hidden landscape of AMR threats. This environmental surveillance approach provides an early warning tool for public health." Jackson Claver, Head of Genomics Department, NPHL.
Dr Vito Baraka, Principal Scientist and lead Investigator in Tanzania, explained that โ€œWES of pathogens and AMR is a radar of population health, what goes down our drains tells a story about our community health. This wastewater and environmental based surveillance provide a complementary tool for detecting early signals in our communities including AMR threats, informing targeted public health interventions, and protecting our communities. The approach is effective, empowering preventive actions and enabling us to take precise measures to safeguard our antimicrobial agents.โ€
Dr Eric Lyimo, co-Investigator in the study highlighted that: "AMR doesn't respect boundaries, and its cross-cutting issue that need multisectoral and multidisciplinary approach. AMR genes from farms, hospitals, and households can mix in our wasteways and environment. Therefore, protecting our antibiotics requires a integrated approach across through One Health concept, cutting across all sectors including human, veterinary and agriculture and environmental ecosystems."
The ODIN project, funded by the European & Developing Countries Clinical Trials Partnership (EDCTP3), is a multinational initiative. The ODIN Consortium brings together North-South partners and integrates high-capacity genomic technologies to advance wastewater surveillance for public health impact. The consortium brings together partners from the National Institute for Medical Research (NIMR) and National Public Health Laboratory (NPHL) in Tanzania, the University of Kinshasa (UNIKIN) in DR Congo, and the Institut de Recherche en Sciences de la Santรฉ (IRSS) in Burkina Faso together with NORCE (Norway), VIB-UGent (Belgium), the TGHN University of Oxford's Global Health Network (UK), the Finnish Institute for Health and Welfare (THL), and Lund University, Sweden. This collaborative platform is dedicated to exchanging technological innovation, strengthening capacity, advancing methodological approaches in WES and translating pathogen genomic data into actionable public health intelligence. This collaborative model ensures that surveillance tools are co-developed, context-specific and validated within the local settings. The project also focused on capacity strengthening to create and strengthen a scalable blueprint for WES across sub-Saharan Africa. . # ODIN

Address

3 Barack Obama Drive
Dar Es Salaam
P.O.BOX9653

Opening Hours

Monday 08:00 - 16:00
Tuesday 08:00 - 16:00
Wednesday 08:00 - 16:00
Thursday 08:00 - 16:00
Friday 08:00 - 16:00

Alerts

Be the first to know and let us send you an email when National Institute For Medical Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to National Institute For Medical Research:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram